IDEAYA Biosciences IDYA
NASDAQ IDYA
$37.86 -0.36 (-0.94%)
At close: Sep 29, 2026 · 4:00 PM EDT

IDEAYA Biosciences (IDYA) Research & Development (2018 - 2026)

Updated

IDEAYA Biosciences' Research & Development came in at $108.69 million for Q2 2026, up 46.4% from $74.23 million a year earlier and up 13.5% from the prior quarter.

Analysis

IDEAYA Biosciences (IDYA) Research & Development (2018 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, IDEAYA Biosciences reported Research & Development of $374.01 million, up 9.2% year-over-year; for FY2025, it came in at $314.7 million, up 6.8% from FY2024.

  • Research & Development has increased in each of the last eight years, with a five-year compound annual growth rate of 51.3% (FY2020 to FY2025).
  • Going back by year, Research & Development was $294.67 million in FY2024 (+127.5%), $129.51 million in FY2023 (+44.6%), $89.54 million in FY2022 (+54.0%) and $58.16 million in FY2021 (+46.5%).
  • The Q2 2026 figure represents the highest quarterly Research & Development since Q4 2024.
  • Year-over-year, Research & Development increased in seven of the last eight quarters, with growth averaging 65.2%.
  • The fastest year-over-year change in Research & Development over five years came in Q4 2024 (growth of 261.6%), and the weakest in Q4 2025 (a decline of 38.2%).
  • Business Quant data shows IDYA's Research & Development at $95.73 million (Q1 2026), $86.6 million (Q4 2025) and $82.99 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 3.65 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 2.34 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -2.85 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -4.05 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 1.87 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 1.76 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.81 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 993.80 Mn
10 IDEAYA Biosciences 3.68 Bn 757.04 Mn - 108.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 108.69 Mn
Mar 31, 2026 95.73 Mn
Dec 31, 2025 86.60 Mn
Sep 30, 2025 82.99 Mn
Jun 30, 2025 74.23 Mn
Mar 31, 2025 70.89 Mn
Dec 31, 2024 140.18 Mn
Sep 30, 2024 57.15 Mn
Jun 30, 2024 54.53 Mn
Mar 31, 2024 42.81 Mn
Dec 31, 2023 38.77 Mn
Sep 30, 2023 33.70 Mn
Jun 30, 2023 29.18 Mn
Mar 31, 2023 27.86 Mn
Dec 31, 2022 24.71 Mn
Sep 30, 2022 22.37 Mn
Jun 30, 2022 22.80 Mn
Mar 31, 2022 19.66 Mn
Dec 31, 2021 16.11 Mn
Sep 30, 2021 15.50 Mn
API Access

IDEAYA Biosciences Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=IDYA&period=max&api_key=YOUR_API_KEY